statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)

Shares of Mind Medicine (MindMed) Inc. MNMD have skyrocketed 154% in the past three months against the industry's decline of 4.2%.The company is progressing well with the development of its lead...

MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why

China Universal Asset Management Co. Ltd. boosted its stake in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 361.4% during the fourth quarter, according to its most recent Form...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Bought by China Universal Asset Management Co. Ltd.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) SVP Chad Gassert sold 20,000 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $67.25...

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) SVP Sells $1,345,000.00 in Stock

--ANI Pharmaceuticals is proud to support Sarcoidosis disease awareness--BAUDETTE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company...

ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis

BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey...

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ANI Pharmaceuticals Inc (ANIP), where a total volume of 3,003 contracts has been...

Noteworthy Monday Option Activity: ANIP, AMC, DOMO

This is a Bearish indicator signaling ANIP's price could decline from here. Traders may explore shorting the stock or put options...

ANI Pharmaceuticals (ANIP, $69.64) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 27, 2024

Shares of Moderna MRNA rose 3% on Wednesday after management announced positive clinical updates at its Vaccines Day Event, highlighting its pipeline progress.While the company provided an update on...

Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Watchers	1,052
52-Wk Low	$44.27
52-Wk High	$70.81

Volume	140,902.00
52-Wk High	$70.81
52-Wk Low	$44.27

ANIP ANI Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community